I agree that this site is using cookies. You can find further informations here.
X
Yogen Saunthararajah
203  results:
Search for persons X
?
1

Oncotherapy resistance explained by Darwinian and Lamarckia..:

Saunthararajah, Yogen
Journal of Clinical Investigation.  134 (2024)  8 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
2

Flow cytometry of DNMT1 as a biomarker of hypomethylating t..:

Woost, Philip G. ; William, Basem M. ; Cooper, Brenda W....
Cytometry Part B: Clinical Cytometry.  106 (2024)  1 - p. 11-24 , 2024
Link: https://doi.org/10.1002/..
 
?
3

MDS-156 Pyrimethamine Shows Synergy and Efficacy in Combina..:

Rivera-Peña, Bianca ; Chakraborty, Samarpana ; Shi, Yang...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S355 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Pharmacokinetics and pharmacodynamics of an oral formulatio..:

Lau, Henry ; Woost, Philip G. ; Friedrich, Ute...
European Journal of Haematology.  111 (2023)  3 - p. 345-355 , 2023
Link: https://doi.org/10.1111/..
 
?
5

POSTER: MDS-156 Pyrimethamine Shows Synergy and Efficacy in..:

Rivera-Peña, Bianca ; Chakraborty, Samarpana ; Shi, Yang...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S181 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Combinatorial targeting of epigenome-modifying enzymes with..:

Ibanez, Vinzon ; Vaitkus, Kestis ; Zhang, Xu...
Blood Advances.  7 (2023)  15 - p. 3891-3902 , 2023
Link: https://doi.org/10.1182/..
 
?
7

DNA Methyltransferase 1 Targeting Using Guadecitabine Inhib..:

Karan, Dev ; Singh, Manohar ; Dubey, Seema..
Cancers.  15 (2023)  10 - p. 2763 , 2023
Link: https://doi.org/10.3390/..
 
?
8

Neuroendocrine lineage commitment of small cell lung cancer..:

Biswas, Sudipta ; Kang, Kai ; Ng, Kwok Peng...
Cell Reports.  42 (2023)  8 - p. 113016 , 2023
Link: https://doi.org/10.1016/..
 
?
9

P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECI..:

Fedorov, Kateryna ; Feldman, Eric ; Saunthararajah, Yogen...
HemaSphere.  7 (2023)  S3 - p. e90768e2 , 2023
Link: https://doi.org/10.1097/..
 
?
10

AML-351 Low-Dose Weekly Decitabine and Venetoclax in Myeloi..:

Shapiro, Lauren ; Mantzaris, Ioannis ; Shastri, Aditi...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S241 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Functional characterization of NPM1–TYK2 fusion oncogene:

Kuravi, Sudhakiranmayi ; Baker, Riley W. ; Mushtaq, Muhammad Umair...
npj Precision Oncology.  6 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
12

Inhibiting DNA methylation and RNA editing upregulates immu..:

Gomez, Stephanie ; Cox, Olivia L ; Walker III, Reddick R...
Journal for ImmunoTherapy of Cancer.  10 (2022)  11 - p. e004974 , 2022
Link: https://doi.org/10.1136/..
 
?
13

Poster: AML-351 Low-Dose Weekly Decitabine and Venetoclax i..:

Shapiro, Lauren ; Mantzaris, Ioannis ; Shastri, Aditi...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S134 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Eltrombopag inhibits TET dioxygenase to contribute to hemat..:

Guan, Yihong ; Hasipek, Metis ; Jiang, Dongxu...
Journal of Clinical Investigation.  132 (2022)  4 - p. , 2022
Link: https://doi.org/10.1172/..
 
?
15

Changing paradigms in oncology: Toward noncytotoxic treatme..:

von Knebel Doeberitz, Nikolaus ; Paech, Daniel ; Sturm, Dominik...
International Journal of Cancer.  151 (2022)  9 - p. 1431-1446 , 2022
Link: https://doi.org/10.1002/..
 
1-15